Back to results
RecruitingPhase 1

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

NCT07465653

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Synergy Healthcare

Bradenton, Florida, United States

+2 additional locations

Contact

Novartis Pharmaceuticals

1-888-669-6682novartis.email@novartis.com
View on ClinicalTrials.gov
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction — TrialFind